Vigabatrin (gamma-vinyl gamma aminobutyric acid), a recently developed anti
epileptic drug, has been extensively evaluated in the treatment of drug-res
istant epilepsy, Several case reports demonstrated that vigabatrin affects
urinary excretion of several amino and organic acids. Fourteen children wer
e investigated for the presence of abnormal urinary amino acids before and
after treatment,vith vigabatrin, All demonstrated increased urinary excreti
on of amino acids, particularly beta-alanine, gamma-aminobutyric acid, and
beta-aminoisobutyric acid while on vigabatrin, which were not detected when
off medication. These results emphasize the importance of obtaining urine
for metabolic evaluation before the administration of vigabatrin. (C) 1999
by Elsevier Science Inc. All rights reserved.